Effect of atracurium and laudanosine on the release of h-noradrenaline

M. Kinjo, H. Nagashima, E. S. Vizi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We examined the effects of atracurium and its breakdown product, laudanosine, on resting and stimulation-evoked release of 3H-noradrenaline (3H-NA) from sympathetic axon terminals of isolated right atria of guineapigs. Both atra-curium 1-100 μmol litre-1 and laudanosine 1-50 μmol litre-1 enhanced the release of 3H-NA evoked by field stimulation (2 Hz, 24 stimuli), but did not affect resting release. When the production of laudanosine from atracurium was inhibited by maintaining the atracurium solution at 4 °C, atracurium did not enhance the release of 3H-NA as occured when it was kept at 37 °C. However, atracurium antagonized the inhibitory effect of oxotremorine on release of 3H-NA, whereas laudanosine did not. These data suggest that atracurium possesses and antimuscarinic effect. Its metabolite, laudanosine, in concentrations which would be expected following prolonged administration of atracurium, produced a marked increase in release of 3H-NA. This effect of laudanosine may explain some of the unwanted effects seen following administration of atracurium.

Original languageEnglish
Pages (from-to)683-690
Number of pages8
JournalBritish Journal of Anaesthesia
Volume62
Issue number6
DOIs
Publication statusPublished - Jun 1989

    Fingerprint

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this